Other hyperlipidemia
Billable / specific
E78.49 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Applicable to
- Familial combined hyperlipidemia
Includes (from E78)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E78)
- androgen insensitivity syndrome (E34.5-) (from E78)
- congenital adrenal hyperplasia (E25.0) (from E78)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E78)
- Marfan syndrome (Q87.4-) (from E78)
- 5-alpha-reductase deficiency (E29.1) (from E78)
- sphingolipidosis (E75.0-E75.3) (from E78)
Excludes2
Not included here — may be reported together when both conditions exist.
Also known as
- Familial combined hyperlipidemia
- Hyperlipemia, hyperlipidemia, combined, familial
- Hyperlipemia, hyperlipidemia, specified NEC